AI-generated story: A story generated by artificial intelligence is created and personalized for pediatric kidney recipient
AI generated story: This is a minimal-risk observational study. Families complete a questionnaire and receive an AI-generated, clinically supervised personalized story. During the pilot phase, there is no direct child-AI interaction. All stories are reviewed by the clinical lead before delivery.
Study summary
Pediatric kidney transplant recipients often face major psychosocial challenges that are difficult to address with existing tools. This study evaluates whether clinically supervised AI can generate personalized, age-adapted therapeutic stories for these children and their families.
Eligibility
Sex
ALL
Min age
5 Years
Max age
12 Years
Healthy volunteers
No
Inclusion Criteria:
* Age 5-12 years inclusive at enrolment.
* Recipient of a kidney transplant.
* Clinically stable at enrolment (no active rejection, acute infection, or current hospitalization for a graft-related complication).
* Fluency in French or English.
* Written informed consent from parent(s)/legal guardian(s); child assent when age-appropriate.
Exclusion Criteria:
* Severe cognitive impairment precluding engagement with narrative content.
* Mental state not allowing participation.
* Family unwilling or unable to commit to the study timeline and interview requirements.
Primary outcome measure(s)
Child and family experience of the story after delivery. — One month after story delivery Child and family experience of the story, assessed through qualitative feedback, thematic analysis, and satisfaction ratings collected after story delivery.
Child and family experience of the story after delivery. — One month after the story is delivered Child and family experience of the story, assessed through qualitative feedback, thematic analysis, and satisfaction ratings collected after story delivery.
Trial sites (1)
Facility
City
Region
Status
Necker hospital
Paris
Île-de-France Region
Recruiting
More Paris Translational Research Center for Organ Transplantation trials in France
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
